As a result of the synovial sarcoma associated t(X;18) translocation, the human SYT gene on chromosome 18 is fused to either the SSX1 or the SSX2 gene on the X chromosome. Although preliminary evidence indicates that the (fusion) proteins encoded by these genes may play a role in transcriptional regulation, little is known about their exact function. We set out to isolate interacting proteins through yeast two hybrid screening of a human cDNA library using SYT as a bait. Of the positive clones isolated, two were found to correspond to the acute leukemia t(10;11) associated AF10 gene, a fusion partner of MLL. Con®rmation of these results was obtained via co-immunoprecipitation of endogenous and exogenous, epitope-tagged, SYT and AF10 proteins from cell line extracts and colocalization of epitopetagged SYT and AF10 proteins in transfected cells. Subsequent sequential mutation analysis revealed a highly speci®c interaction of N-terminal SYT fragments with C-terminal AF10 fragments. The N-terminal interaction domain of the SYT protein was also found to be present in several SYT orthologs and homologs. The C-terminal interaction domain of AF10 is located outside known functional domains. Based on these results, a model is proposed in which the SYT and AF10 proteins act in concert as bipartite transcription factors. This model has implications for the molecular mechanisms underlying the development of both human synovial sarcomas and acute leukemias. Oncogene (2001) 20, 3281 ± 3289.
Introduction
Synovial sarcoma is a soft tissue tumor predominantly aecting children and young adults. Cytogenetically, this tumor is characterized by the presence of a recurrent chromosomal translocation, t(X;18)(p11.2;q11.2) (Turc-Carel et al., 1987; Geurts van Kessel et al., 1997) . Recently, using positional cloning strategies, it was found that as a result of this translocation the SYT gene on chromosome 18 is fused to either of two closely related SSX genes on the X chromosome, SSX1 or SSX2 (Clark et al., 1994; de Leeuw et al., 1995; Crew et al., 1995) . Interestingly, the occurrence of either SYT-SSX1 or SYT-SSX2 appears to correlate to the histological tumor phenotype, biphasic or monophasic, respectively (de Leeuw et al., 1994) and disease prognosis (Kawai et al., 1998) . The SSX1 and SSX2 genes belong to a family of which six members have now been identi®ed Gure et al., 1997; dos Santos et al., 2000a) . Recently, also the SSX4 gene was shown to be fused to SYT in a case of synovial sarcoma (Skytting et al., 1999) . The SSX encoded proteins reside in the nucleus, where they exhibit a more or less diuse staining pattern (dos Brett et al., 1997) . Both proteins contain an acidic C-terminal tail and, in their N-terminus, a putative KruÈppel-associated box or KRAB (Crew et al., 1995; Lim et al., 1998) . KRAB-domains were originally described as transcriptional repressor domains in the Drosophila KruÈppel gene product and have also been found in a subgroup of zinc ®nger proteins (Bellefroid et al., 1991; Margolin et al., 1994; Witzgall et al., 1994) . Functional studies have shown that the acidic C-terminus of SSX2 carries yet another repressor domain (Brett et al., 1997; Thaete et al., 1999) which was designated SSXRD (Lim et al., 1998) . In addition, the SSX proteins were found to colocalize with several members of the Polycomb group proteins (Lim et al., 1998) .
The SYT gene and its encoded protein are well conserved over evolution (de Bruijn et al., 1996 (de Bruijn et al., , 2001 . RNA in situ hybridization analysis on mouse sections has revealed ubiquitous expression in early stages of embryonic development. In later stages this expression becomes con®ned to mainly cartilagineous and speci®c neuronal cells, as well as some epithelial derived tissues. In the adult mouse, Syt expression was detected in several organs, most markedly in heart, kidney and testis (de Bruijn et al., 1996) . Using immuno¯uorescence, it was shown that the SYT protein resides in the nucleus where it exhibits a punctate pattern (dos . Since no colocalization could be found with other nuclear structures, it was suggested that SYT may be part of a new class of nuclear (sub-) domains (dos Brett et al., 1997) . The SYT protein is rich in glutamine, proline, glycine and tyrosine residues. In addition, it exhibits four putative src-homology binding domains (Clark et al., 1994) and two annexin-like direct repeats (de Bruijn et al., 1996) . Recently, two new domains were de®ned in the SYT protein. First, the SYT N-terminal Homology (SNH) domain which shows homology to the predicted protein products of EST clones derived from a wide variety of species, ranging from plants to human (Thaete et al., 1999; de Bruijn et al., 2001) . Second, the C-terminal QPGY domain which is rich in glutamine, proline, glycine and tyrosine (Thaete et al., 1999; de Bruijn et al., 2001) . This domain was shown to activate transcription when coupled to a DNA binding domain (Brett et al., 1997; Thaete et al., 1999) . The latter ®nding is compatible with the notion that proline/glutamine rich proteins may act as such (Verrijzer and Tjian, 1996) . Since the SYT protein lacks obvious DNA binding domains, it has been assumed that it functions as a co-activator of transcription (Brett et al., 1997) . As a consequence, interactions with other nuclear factors may be essential for a correct targeting to speci®c transcriptional complexes. Additionally, colocalization and in vitro association of the SYT protein with the Brahma protein (BRM) was found, indicating that there is a link to the SWI/SNF family of proteins (Thaete et al., 1999) . Recently, the SYT protein was found to co-immunoprecipitate with the p300 protein (Eid et al., 2000) . The observed SYT-p300 complexes were located in the nucleus and were shown to be dynamically regulated with respect to the state of cell adhesion. In most of the the SYT-SSX fusion proteins characterized to date, the C-terminal 8 amino acids of SYT are replaced by the C-terminal 78 amino acids of SSX (Clark et al., 1994; de Leeuw et al., 1995; Crew et al., 1995) . As a consequence, part of the QPGY domain of SYT, and the complete KRAB domain of SSX are lost. The main body of the SYT protein, including the SNH domain, is fused to the highly polar C-terminal SSX tail, including the SSX repressor domain (SSXRD). Through this fusion, the normal function of SYT is thought to be altered in such a way that it triggers tumor development.
Here, we have searched for SYT-interacting proteins through yeast two hybrid screening. Our data indicate that the SYT protein interacts in vivo with AF10. This protein was originally identi®ed as a fusion partner to MLL in t(10;11) positive acute leukemias and is a member of the zinc ®nger/leucine zipper family of putative transcription factors (Chaplin et al., 1995a) . This newly observed SYT/ AF10 interaction provides a link between two dierent tumor types, i.e., synovial sarcomas and acute leukemias, and may have implications for the pathogenesis of both of them.
Results

Two hybrid screening with SYT
Since the SYT gene shows abundant expression in the testis (de Bruijn et al., 1996) , we decided to use a testis cDNA library for our yeast two hybrid experiments. This library was constructed with RNA extracted from normal human testis and the hybriZAP cloning system. Screening of this library with full length SYT, fused to the GAL4 DNA binding domain, yielded high background levels. The same was true for clones containing only C-terminal fragments of SYT. Others have shown that this region, which is particularly rich in glutamines, prolines and glycines, is able to activate transcription in an in vitro system (Brett et al., 1997; Thaete et al., 1999) . This potential may explain the observed lack of speci®city. Only when we used an Nterminal fragment of SYT, containing the ®rst 161 amino acids (Figure 1 Further analysis revealed that half of these clones were derived from two independent, but clonally expanded, cDNAs of approximately 2 and 3 kb, respectively. Retransformation of these two preys together with the SYT bait con®rmed the positive yeast two hybrid interaction. Co-transformation of both preys with two standard control plasmids expressing lamin-B and p53 turned out negative, thereby validating the yeast two hybrid interaction observed. Sequence analysis and database assisted homology searching revealed that both cDNAs correspond to human AF10, a gene that was previously identi®ed as a fusion partner of the MLL gene in t(10;11)-positive human acute leukemias (Chaplin et al., 1995a, b) . The two interacting cDNAs, prey 12 and prey 21, start at nucleotide 1775 (amino acid 535) and 2177 (amino acid 660) of the published AF10 sequence (Chaplin et al., 1995a) and code for proteins of 569 and 419 amino acids, respectively. The 3'-ends of both cDNAs carry a poly(A) + tail. Prey 12 lacks a previously published alternatively spliced exon between nucleotides 1882 and 1929 (Chaplin et al., 1995a) . Furthermore, we found that the predicted proteins of both preys extend further at their Cterminus and have a dierent composition than the published protein. However, recent comparisons of AF10 with its mouse ortholog Af10 indicated that this ®nding, again, may be attributed to the presence of an alternatively spliced exon (Linder et al., 1998) .
SYT and AF10 colocalize in transfected cells
For a further validation of the SYT/AF10 interaction, we determined the sub-cellular localization of both proteins using immuno¯uorescence assays. Therefore, the longest SYT-interacting AF10 cDNA (prey 12, Figure 1 ), a full length AF10 cDNA (Chaplin et al., 1995a; Linder et al., 1998) and two C-terminally truncated AF10 cDNAs (AF10-29 and AF10-37, coding for amino acids 1 ± 1055 and 1 ± 972, respectively; Figure 2 ) were cloned in-frame with the enhanced green¯uorescent protein (EGFP). A full length SYT cDNA was cloned in frame with the VSVtag (dos . After co-transfection of the dierent VSV-SYT/EGFP-AF10 combinations into COS1 cells and (immuno-)¯uorescent detection of the VSV-tag and EGFP, all resulting signals were compared. In SYT and full length AF10 or AF10-37 double transfected cells green (AF10) and red (SYT) signals were observed, both in punctate con®gurations ( Figure 2a ,b,e,f). After overlay a mixed (yellow) color was observed for all signals (Figure 2c ,g), which is indicative for a complete colocalization. DAPI counterstaining ( Figure 2d ,h) indicated that the colocalizing signals were present in the nucleus. Similar experiments with a FLAG-tagged SYT-SSX2 fusion protein (dos and full length AF10 again showed complete nuclear colocalization in a punctate fashion (not shown). A punctate pattern of colocalizing signals was also observed after transfection of COS1 cells with full length SYT and prey 12, but in this case the signals were present in both the cytoplasm and the nucleus (not shown). This loss of nuclear speci®city can be attributed to the absence of the bipartite nuclear localization signal from prey 12 ( Figure 1 ; Linder et al., 2000) . Co-transfection of SYT together with AF10-29 resulted in a complete loss of colocalization (Figure 2i ± k). Whereas the SYT protein still showed a punctate nuclear staining, in this case the AF10-29 protein displayed a diuse nuclear staining, suggesting loss of the SYT/AF10 interaction due to the Cterminal AF10 truncation.
Endogenous and epitope-tagged SYT and AF10 co-immunoprecipitate
Since AF10 was originally identi®ed as a fusion partner of MLL in acute leukemias and since full length cDNAs were isolated from a Jurkat lymphoblastoid cell line derived library (Chaplin et al., 1995a) , we decided to test a panel of hematopoietic cell lines for the expression of SYT and AF10. Using RT ± PCR, we found that both genes are expressed in cell lines HL60, K562 and U937 (not shown). Immunoprecipitations were carried out using the rabbit polyclonal anti-SYT antibody C44 (dos and the rabbit polyclonal anti-AF10 antibody HAF10 (Linder et al., 1998) on protein extracts of these three cell lines. The resulting precipitates were tested for the presence of the SYT protein on Western blots using the same anti-SYT antibody. Positive signals of approximately 63 and 50 kDa (de Bruijn et al., 2001) were observed in all three cell line extracts (Figure 3a , lanes 7 ± 9; closed arrowheads right). Since we have used polyclonal antibodies for both immunoprecipitation and detection, the blot shows two antibody Fc fragments (55 and 22 kDa) in all lanes containing immunoprecipitates (Figure 3a , lanes 1 ± 6, open arrowheads). A positive signal for the 63 kDa SYT fragment was observed in the anti-SYT immunoprecipitates (Figure 3a , lanes 1 ± 3; closed arrowhead left), while the 50 kDa fragment was obscured by the Fc fragments. In addition, a clearly positive 63 kDa SYT signal was observed in the anti-AF10 immunoprecipitate of cell line HL60 ( Figure  3a , lane 4; arrow), indicating that endogenous SYT and AF10 proteins do associate in vivo. The SYT protein was not readily visualized in the anti-AF10 immunoprecipitates from the other two cell lines (Figure 3a , lanes 5 and 6), but upon longer exposure a band of correct size was found to be present in those lanes as well. To further validate these in vivo results, we have generated two HEK293 derived cell lines with stable expression of either EGFP-AF10 or EGFP-prey 12 protein. In addition, these cell lines were engineered in such a way that SYT expression (myc-tagged) can be induced by the addition of tetracyclin to the culture medium. Protein extracts of these induced cell lines were subjected to immunoprecipitations with the rabbit polyclonal anti-SYT antibody C44, a commercially available mouse monoclonal anti-myc antibody and a polyclonal rabbit anti-EGFP antibody. A rabbit preimmune serum was included as a control. Western blots, containing the protein extracts and the immunoprecipitates were subsequently incubated with the monoclonal anti-myc antibody. This resulted in clear detection of the SYT-myc protein in the extracts, as well as in the C44 and anti-myc immunoprecipitates from both HEK293-derived cell lines (Figure 3b, c, lanes 1, 3, 4; arrow) . No SYT-myc protein was observed when the rabbit pre-immune serum was used for immunoprecipitation (Figure 3b ,c, lane 2). In addition, SYT-myc protein could be detected in the anti-EGFP immunoprecipitates from both cell lines (Figure 3b ,c, lane 5), again indicating that the SYT protein interacts in vivo with the AF10 protein.
Refinement of the SYT/AF10 interaction
For a more precise identi®cation of the domains involved in the SYT/AF10 interaction, we created a series of deletion mutants from both cDNAs and tested them for interaction in the yeast two hybrid system. Reduction of the original N-terminal 161 amino acidslong SYT fragment (used for the selection of AF10) to 128 and 90 amino acids still yielded positive interaction scores. A further deletion to 60 amino acids resulted in complete loss of the interaction. Also, an N-terminally Figure 2 Detection of VSV-SYT (a,e,i; red) and EGFP-AF10 full length (b; green), EGFP-AF10-37 (f; green) and EGFP-AF10-29 (j; green) in co-transfected COS1 cells. After overlay of these images a complete colocalization can be observed for VSV-SYT and both EGFP-AF10 and EGFP-AF10-37 (c,g; yellow). DAPI counterstaining indicates a nuclear localization of all colocalizing signals (d,h). VSV-SYT (i) and the C-terminally truncated EGFP-AF10-29 (j) exhibit a complete loss of colocalization in the nuclear compartment (k,l) deleted fragment, containing amino acids 53 ± 161, turned out to be negative. Interestingly, the SYT fragment containing the ®rst 90 amino acids showed a stronger interaction with AF10 than the longer SYT fragments, as measured by b-galactosidase activity (Figure 1) . Also, this fragment showed some transactivation in yeast in the absence of AF10. Subsequent addition of 3-aminotriazole (3-AT; Kanazawa et al., 1988) to the growth media and the use of a dierent yeast strain (pJ69-4A), permitting extra selection on adenine auxotrophy, completely abolished the latter background. The strong interaction with AF10, however, was retained. Therefore, we conclude that the N-terminal 90 amino acids of SYT harbor the functional interaction domain. Similarly, the interaction domain of AF10 could be located in a region between amino acids 812 and 1001, thereby excluding known functional motifs such as the zinc ®nger like PHD or LAP ®ngers (Linder et al., 1998; Aasland et al., 1995; Saha et al., 1995) , the cruciform DNA binding AT hook (Linder et al., 2000; Huth et al., 1997) and the leucine zipper (Figure 1 ; Chaplin et al., 1995a) . This latter observation is in complete accord with the cellular colocalization studies described above.
The SNH domains of the human SYT and SYT-hmlg2 proteins interact with AF10
The minimal AF10 binding domain of SYT (amino acids 1 ± 90) contains the previously identi®ed SNH domain (amino acid 21 ± 67). Since the deletion fragment carrying amino acids 1 ± 60 showed no interaction (Figure 1 ) we decided to extend our study of the SYT-AF10 interaction to the role of the SNH domain. Originally, the SNH domain was identi®ed in EST sequences derived from a wide variety of species ranging from plants to human (Thaete et al., 1999) . Further analysis of these EST sequences indicated that some of them are derived from the SYT orthologs in mouse, zebra®sh and xenopus, while others are derived from novel SYT homologous genes (SYT-hmlg) from human, mouse and rat (Thaete et al., 1999; de Bruijn et al., 2001) . Of these homologs, the SYT-hmlg2 genes carry open reading frames of 234 nucleotides (76 amino acids), coding for predicted proteins of 8.7 kDa composed almost entirely of single SNH domains. The degree of homology between the human and mouse SYT proteins and the predicted SYT-hmlg2 proteins is high in the ®rst 66 amino acids, extending beyond the limits of the SNH domain (Figure 4 ). To check whether these proteins may also interact with AF10, we cloned the full length human and mouse SYT-hmlg2 cDNAs into the yeast two hybrid vector pBD-GAL4. When human and mouse SYT-hmlg2 cDNAs were tested together with the AF10 preys (in pAD-GAL4) in our yeast two hybrid assay, again a strong interaction was observed for both proteins (data not shown). Using the prosite database (Bairoch et al., 1997), we detected a consensus tyrosine phosphorylation site (amino acids 43 ± 50; Figure 4 , underlined) within the SNH domain of the SYT and SYT-hmlg2 proteins. Since tyrosine phosphorylation may play an important role in protein ± protein interaction and protein tracking (Schlessinger, 1994; Pawson, 1995) , this conserved tyrosine phosphorylation motif may serve to modulate the various interactions.
Discussion
Through yeast two hybrid screening, using the synovial sarcoma associated protein SYT as a bait, two cDNAs were isolated which correspond to AF10, a putative transcription factor which is deregulated in t(10;11) positive acute leukemias. The SYT/AF10 interaction could be validated via cellular colocalization studies and co-immunoprecipitation of endogenous and exogenous, epitope-tagged, proteins. Through sequential mutation, the minimal functional interaction domains in both proteins could be de®ned. Both interaction domains are retained in the t(X;18) and t(10;11) associated SYT-SSX and MLL-AF10 fusion proteins in synovial sarcomas and acute leukemias, respectively (Clark et al., 1994; de Leeuw et al., 1995; Crew et al., 1995) . Within the AF10 interacting region of SYT, the so-called SYT N-terminal homology (SNH) domain is present (Thaete et al., 1999; de Bruijn et al., 2001) , which includes a consensus tyrosine phosphorylation motif. This SNH domain is also contained within several highly homologous SYT-hmlg proteins which, again, interact with AF10 in the yeast two hybrid system.
The AF10-interaction domain of SYT, containing the ®rst 90 amino acids, exhibited a stronger interaction than the original SYT bait of 161 amino acids. Since the deleted fragment (amino acids 90 ± 161) is rich in prolines (21%), the resulting size reduction leads to a substantial decrease in overall proline content (from 15 to 8%). Since proline residues are known to introduce rigid kinks in polypeptide chains, this decrease may have a profound eect on protein folding and, through a better exposure of the interaction domain, on the interaction with AF10. Through sequential deletions, the SYT interaction domain of AF10 could be localized between amino acids 812 and 1001, well outside known peptide motifs like the PHD/LAP ®ngers, the AT hook and the leucine zipper domain. Database searches with this region of AF10 did not reveal any strong homologies to other genes, including the previously identi®ed AF10-related genes AF17, Br140 and CEZF (Saha et al., 1995) .
Although the SYT protein lacks obvious DNA binding motifs, preliminary results have indicated that it may act as a transcriptional co-activator (Brett et al., 1997; Thaete et al., 1999) . The AF10 protein, on the other hand, exhibits several characteristics typical of transcription factors, including the PHD/LAP ®ngers, speci®c zinc ®nger-like structures that may mediate oligomerization of proteins (Aasland et al., 1995; Linder et al., 2000) , a high anity HMG-I type-I DNA binding domain or AT hook, which has been shown to bind cruciform DNA in vitro (Huth et al., 1997; Linder et al., 2000) and a leucine zipper dimerization domain (Chaplin et al., 1995a) . Based on our ®nding that SYT and AF10 interact in vivo, a model emerges in which both proteins act in concert as a bipartite transcription factor ( Figure 5) . Consequently, in non-malignant cells, the SYT protein may be targeted to speci®c gene promoters through the interaction with AF10 (Figure 5a ). This notion is in agreement with our ®nding that C-terminal truncation of AF10 (including the SYT interaction domain) results in loss of nuclear colocalization. Previously, it was found that both the SYT and SYT-SSX proteins display a punctate pattern in the nuclear compartment (dos Brett et al., 1997) . Upon careful immuno-detection analysis, we found that the SYT and SYT-SSX fusion proteins do not completely colocalize (dos Santos et al., 2000b) . Since the SYT-SSX fusion proteins include the almost complete SYT sequence and, in addition, the C-terminal 78 amino acids of SSX, the latter region most likely accounts for this subtle change in nuclear localization. The Nterminal part of SSX contains a putative KRAB domain, which was found to exhibit gene repression in an in vitro assay (Crew et al., 1995; Lim et al., 1998) . Functional KRAB domains have been shown to interact with co-repressors like KAP1 (Friedman et al., 1996; Kim et al., 1996; Moosmann et al., 1996) , which is a member of the RING ®nger family of proteins (Freemont, 1993) , some of which have been implicated in transcriptional silencing via the multimeric Polycomb group protein complex (Epstein, 1992; Singh, 1994; Satijn et al., 1997) . Teleologically, it may be assumed that the C-terminal part of SSX normally directs the protein to speci®c inactive chromatin domains and that the N-terminal part of SSX mediates gene repression. In synovial sarcoma, the SYT-SSX protein may be directed to these same chromatin domains and the AF10 protein may, through its interaction with ectopic SYT, interfere with the normal regulation of transcription in these domains ( Figure  5b ). Additional modulation of transcriptional regulation may come from the C-terminal SSX repressor domain SSXRD (Lim et al., 1998) , the binding of SYT to the SNF protein BRM (Thaete et al., 1999) and the complexes SYT can form with p300 (Eid et al., 2000) . In t(10;11) positive acute leukemias similar mechanisms may be at work (Figure 5c,d) . Most MLL-AF10 fusion products characterized to date contain the MLLderived DNA binding AT-hook (Tkachuk et al., 1992; Djabali et al., 1992) and methyltransferase (Ma et al., 1993; Slany et al., 1998) , in addition to the C-terminal part of AF10 carrying the leucine zipper (Chaplin et al., 1995a) and SYT interaction domain (this study). These chimeric transcription factors may have, by virtue of the C-terminal AF10 sequence, gained the potential to bind SYT. As a consequence, the SYT-associated transcription transactivation machinery may be recruited to genes that are normally regulated by MLL. Through the MLL-AF10 fusion, MLL has lost its SET domain (Stassen et al., 1995; Tschiersch et al., 1994) and, thereby, its link to both the histone modifying SWI/SNF protein complex (Rozenblatt-Rosen et al., 1998) and the multimeric Polycomb group protein complex (Jenuwein et al., 1998; Tripoulas et al., 1996) . Modulation of the activitities described in this model may come from the SYT-hmlg2 protein. Since this protein is also able to interact with the AF10 protein, but obviously lacks the transactivating QPGY domain, it may function as a negative regulator of the transcriptional activation brought about by the SYT-AF10 complex. Thus, in a normal situation the SYT and SYT-hmlg2 proteins may compete for SYT binding sites on AF10 proteins (Figure 5e,f) thus aecting the expression of downstream target genes. Together, these protein modi®ca-tions are expected to interfere with the normal control over genes that govern growth and, as such, may lead to malignancy.
Materials and methods
Cloning and sequencing procedures
All cloning procedures were essentially as described before (de Bruijn et al., 1994 (de Bruijn et al., , 1996 . Sequence analyses were performed using the Dye-deoxy-terminator kit from Applied Biosystems. Samples were run on an ABI 373 sequencer and analysed with the sequence navigator (Applied Biosystems). DNA and protein databases were searched using the BLAST package of search algorithms at http://www.ncbi.nlm.nih.gov/ blast/. The prosite database was searched at http://www. expasy.ch/sprot/scnpsit1.html. The bait fragment, carrying amino acids 1 ± 161, was isolated from a full length SYT cDNA and cloned in frame with the GAL4 DNA binding domain into the pBD-GAL4-Cam vector (Stratagene). For easy cloning of selected interactors and all deletion fragments in frame with the GAL4 transactivation or DNA binding domains, we adapted the pGAD10 (Clontech) and pBD-GAL4-Cam vectors. These adapted vectors (pGAD10-T1C, T2C and T3C; pBD-T1C, T2C and T3C) facilitate the cloning of inserts in three dierent reading frames. All deletion fragments of SYT and AF10 were generated by PCR with speci®c oligonucleotide primers. PCR products were sub-cloned into pGEM-T (Promega) and, after veri®cation by sequencing, cloned into the correct pBD, pGAD10 or pEGFP vector.
Yeast two hybrid screening
Yeast two hybrid screening was performed using a human testis cDNA library. For the construction of this library, poly(A) + RNA was isolated using OLIGOTEX (Qiagen) and, after reverse transcription, cloned into hybriZAP (Stratagene). The resulting primary phage library contained 4610 6 independent clones. Approximately 1610 6 clones were ampli®ed once and 1610 9 of the resulting plaque forming units were mass-excised according to manufacturers' instructions to generate the cDNA library in pAD-GAL4. The average insert size of this library was estimated to be around 1 kb. The yeast strain used for the interaction traps was YRG-2, supplied with the hybriZAP kit (Stratagene). For all interaction studies with the deletion constructs, another yeast strain (pJ69-4A; a kind gift from Philip James) was used. Positive interactions in this yeast strain can be selected for by adenine auxotrophy, next to histidine auxotrophy and bgalactosidase activity. For the yeast two hybrid interaction studies, yeast strain YRG-2 was transformed with the bait plasmid pBD-GAL4-SYT and the testis cDNA library (in Figure 5 Model depicting the consequences of SYT-SSX (synovial sarcoma; a and b) and MLL-AF10 (acute leukemia; c and d) fusions, as well as a modeled role of the SYT-hmlg2 protein (e and f). In the normal situation, the SYT/AF10 complex is, directly or indirectly, tethered to DNA where it exerts its transactivating functions (a). After fusion with SSX these transactivating functions are modulated, leading to aberrant gene transcription (b; synovial sarcoma). MLL may bind to DNA and act as a transcription factor in normal cells (c). Through the MLL-AF10 fusion, SYT can be recruited to this complex and alter gene transcription via its transactivating capacities (d; acute leukemia). Loss of interaction with the SWI/SNF complex has another, probably synergistic, eect. Both fusions may result in aberrant targeting of the transcription complexes to dierent (sets of) genes. Obviously, other domains of AF10, like the leucine zipper, may be necessary for correct complex formation with other, yet unidenti®ed, nuclear factors. SYT-hmlg2 and SYT proteins may compete for binding to AF10, thus leading to modulation of the complex and the downstream target genes involved (e and f, also in a,b and d). (ATH: AT-hook, SNH: SYT N-terminal homology domain; LZ: leucine zipper; MTH: methyltransferase homology domain; SET: SET domain) pAD-GAL4). Subsequent selection was carried out on SDmedium lacking leucine and tryptophan. Approximately 3610 5 double transformants were harvested and replated on selective medium lacking leucine, tryptophan and histidine, supplemented with 25 mM of 3-Aminotriazole (3-AT; Sigma). LacZ activity was determined for all growing colonies using a ®lter lift assay according to the manufacturers' instructions. Clones were scored as positive when blue staining started within 30 min at 308C and became intense over the next 2 h. The cDNA inserts of positive clones were isolated by direct PCR on yeast colonies with two pAD-GAL4 speci®c oligonucleotides, AD-for (CTGT-CACCTGGTTGGACGGACCAA) and pGAD-rev (GTGA-ACTTGCGGGGTTTTTCAG). After sequencing of the PCR products, the interacting cDNA inserts were cloned into the correct pGAD10 vector and retransformed together with the SYT bait into YRG-2 to con®rm the previously found interaction. The interaction strength between all SYT and AF10 deletion constructs was measured by the growth speed of doubly transformed yeast cells on fully selective medium and by the relative b-galactosidase activity in the same set of transformants. Yeast growth curves were made for all transformants and the mean OD 600 increase was determined. Beta-galactosidase assays were performed with the substrate o-nitrophenyl b-D-galactopyranoside (ONPG) in liquid cultures. All scores are presented as percentages of the highest value (Figure 1 ).
Transfections and immunofluorescence assays
Green monkey kidney COS1 cells were grown on poly-Llysine (Sigma) coated glass slides in DMEM containing 10% fetal calf serum (Gibco) and transiently transfected by lipofection. For each transfection, 10 mg of each of the appropriate plasmid DNAs, pEGFP-AF10 full length, pEGFP-prey12, pEGFP-AF10-37 or pEGFP-AF10-29 were mixed with pSG8-VSV-SYT and added to the DOSPER lipofection reagent (Boehringer) in a ratio of 1 : 4 and overlayed on growing cells in DMEM without fetal calf serum. After 6 h, transfections were stopped by removal of the transfection mixture and the addition of fresh culture medium. The transfected cells were grown for another 16 ± 18 h prior to a 30 min ®xation in 3% formaldehyde. Immuno¯uorescent detection of the VSV and EGFP tagged proteins was performed as described previously (dos . For the immunoprecipitation analysis of epitope-tagged SYT and AF10 proteins, we used the T-rex system (Invitrogen) to attain inducible expression of the myctagged SYT protein. First, the SYT open reading frame (without the stop codon) was cloned into the pcDNA4/TO/ myc-His(A) vector to generate an in-frame fusion of the SYT protein with the myc-His-tag. By electroporation, this construct was transfected into the human embryonic kidney cell line HEK293, stably expressing the tetracyclin repressor protein (T-REx-293, Invitrogen). After zeocin selection a stable cell line was obtained which showed SYT-myc expression upon tetracyclin induction. Subsequently, these cells were electroporated with either pEGFP-AF10 full length or pEGFP-prey12 constructs. The percentage of EGFP positive cells was estimated to be 20 ± 30% by immuno¯uor-escence and¯uorescence assisted cell sorting (FACS). After 24 h tetracyclin induction the cells were harvested and lysed for the preparation of protein extracts.
Immunoprecipitation analyses
Protein extracts were prepared by lysing 1610 7 cultured cells for 15 min at 08C in 500 ml extraction buer containing 150 mM NaCl; 0.5% NP-40; 50 mM HEPES (pH 7); 5 mM EDTA; 1 mM PMSF; 0.5 mM DTT; 2 mg/ml leupeptin and 2.5 mg/ml aprotinin. The cell lysates were centrifuged for 10 min at 14 000 r.p.m. (48C) and the supernatants were stored at 7708C. As starting material for immunoprecipitation, 50 ml lysate was used. Depending on the nature of the antibody used for immunoprecipitation, either Goat-antirabbit-IgG or Goat-anti-mouse-IgG coupled to protein-Aagarose (Sigma) was used. The agarose beads were prewashed with IPP500 buer (10 mM Tris-HCl [pH 8]; 500 mM NaCl; 0.1% NP-40; 0.1% and incubated overnight at 48C with 10 ml of the appropriate antibody in 500 ml IPP500. The resulting antibody-coupled agarose beads were washed twice with IPP500 and twice with IPP150 (10 mM Tris-HCl [pH 8]; 150 mM NaCl; 0.1% NP-40; 0.1% Tween-20) after which the cell lysates and 450 ml IPP150 were added. The whole mixture was incubated for 2 h at 48C under continuous mixing. After four subsequent washes with cold IPP150, the agarose pellet was boiled in protein sample buer. The proteins were separated by standard polyacrylamide gel electrophoresis (SDS ± PAGE) and transferred to nitrocellulose ®lters. Generally, 2.5 ml of the cell lysate was loaded as an input control. Western blots were incubated with the rabbit polyclonal anti-SYT antiserum C44 (dos or the mouse monoclonal myc antibody (Invitrogen). As secondary antibody, either horseradish peroxidase (HRP) coupled swine-anti-rabbit-IgG (Dako) or HRP coupled rabbit-anti-mouse-IgG (Dako) was used. The ECL system (Amersham) was used for detection on X-omat R X-ray ®lms (Kodak).
